The HALP score, which is a combined index composed of hemoglobin, albumin, lymphocyte, and platelet, is a new indicator showing both inflammation and nutritional status. This study aims to evaluate the relationship of this combined index consisting of simple laboratory values with the degree of appendicitis complication and postoperative results in patients operated on for acute appendicitis. The data of 684 patients operated for acute appendicitis between January 2017 and December 2022 and inclusion criteria were analyzed with a single-center retrospective cross-sectional study design. Using routine laboratory data, patients' HALP scores were divided into two groups as low and high. The cut-off value of the HALP score according to the presence of postoperative complications was determined as < 31.2 by ROC analysis and the ROC curve. Patients were grouped as HALP score cut-off value below (group 1) and above (group 2). Complicated appendicitis and postoperative outcomes were compared to the HALP score groups. According to the cut-off value of the HALP score, 113 (16.5%) of the patients were in Group 1, and 571 (83.5%) were in Group 2. Complications developed in 15 (26%) patients (p < 0.001). Low HALP scores were a significant risk factor for peri-appendicular abscess (OR 29.12 95% CI 12.39-68.43), appendicitis perforation (OR = 20.82 95% 12.67-34.19), gangrenous appendicitis (OR = 35, 54, 95% 13.33-94.77), and postoperative complications (OR = 15.29 95% 7.95-29.41) (p < 0.001). Besides clinical and radiological findings, the HALP score shows the degree of acute appendicitis complication. It can be used as a simple, inexpensive, and easily applicable diagnostic tool.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13304-023-01513-8DOI Listing

Publication Analysis

Top Keywords

halp score
12
acute appendicitis
12
hemoglobin albumin
8
patients operated
8
operated acute
8
efficacy hemoglobin
4
albumin lymphocytes
4
lymphocytes platelets
4
halp
4
platelets halp
4

Similar Publications

Objective: The high hemoglobin, albumin, lymphocyte, and platelet (HALP) score has been reported to be a good prognostic indicator for several malignancies. However, more evidence is needed before it can be introduced into clinical practice. Here, we systematically evaluated the predictive value of HALP for survival outcomes in patients with solid tumors.

View Article and Find Full Text PDF

Background: Recent studies have revealed that inflammatory factors and nutritional status of patients with advanced gastric cancer (AGC) are related to the efficacy of drug therapy and patient prognosis. This study seeks to evaluate the correlation between inflammatory markers, nutritional status, and clinical outcomes of immune checkpoint inhibitor (ICI)-based therapies among inoperable AGC patients.

Method: This retrospective study included 88 AGC patients who received ICIs combined with chemotherapy.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate how the combination of HALP score and TTCR score influences overall survival (OS) and progression-free survival (PFS) in prostate cancer patients who developed castration resistance.
  • A total of 152 metastatic prostate cancer patients were analyzed, categorized based on median cut-off values for HALP (30.83 months) and TTCR (16.1 months), resulting in three risk stratification groups.
  • The findings indicated that lower HALP scores and shorter TTCR were linked to significantly worse PFS, and that combining these factors improved predictions for OS and PFS in patients with metastatic castration-resistant prostate cancer (mCRPC).
View Article and Find Full Text PDF

Blood-Based Clinical Biomarkers of Inflammation and Nutrition in Hyperemesis Gravidarum.

J Clin Med

November 2024

Department of Obstetrics and Gynecology, Health Sciences University Etlik Zubeyde Hanim Maternity, Teaching and Research Hospital, 06010 Ankara, Turkey.

: In this study, the aim was to investigate blood-based clinical biomarkers of inflammation and nutrition indices in hyperemesis gravidarum (HG). : This retrospective case-control study was conducted at a tertiary hospital between 2018 and 2022. A total of 820 pregnant women were enrolled in this study; 410 pregnant women were diagnosed with HG (HG group) at 6-14 weeks of gestation, and 410 pregnant women were healthy controls (control group) in the same gestational weeks.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!